Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | Unknown | PO / MO |
The patient took last dose of Vivotif on 02-Apr-2025 or 01-Apr-2025 but the medication had expired in end of February; Case reference number US-BN-2025-000420 is a spontaneous case initially received from pharmacist via agency (reference number: USBAV25-0734) on 02-Apr-2025 and concerns an adult female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took the first, second and third doses Vivotif vaccine (batch number: unknown) at unknown dose, orally, for unknown indication. On 01-Apr-2025 (yesterday) or 02-Apr-2025 (today), unknown amount of time after the first dose, the patient took last dose of Vivotif (batch number: unknown) at unknown dose, orally, but the medication had expired in end of February (unspecified year) (explicitly coded as 'expired vaccine used'). At the time of the initial report, it was unknown if the patient experienced any of the adverse events due to Vivotif. No further information was provided.; Reporter's Comments: An adult female patient of unknown age had received Vivotif vaccine for unknown indication. As reported, patient had taken the last dose (fourth) of Vivotif vaccine which was expired, on unknown date from the first dose, which is considered as expired vaccine used. It was unknown if patient experienced any adverse events due to Vivotif. Expired vaccine used is considered as listed as per company convention. The patient's medical history and concomitant medication details were not provided. Event expired vaccine used is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: An adult female patient of unknown age had received Vivotif vaccine for unknown indication. As reported, patient had taken the last dose (fourth) of Vivotif vaccine which was expired, on unknown date from the first dose, which is considered as expired vaccine used. It was unknown if patient experienced any adverse events due to Vivotif. Expired vaccine used is considered as listed as per company convention. The patient's medical history and concomitant medication details were not provided. Event expired vaccine used is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None